Lexington’s Alzheon gives its own Alzheimer’s news to rival Biogen’s

While it’s the biggest, Biogen is not the only Bay State biotech presenting promising data for an Alzheimer’s drug this morning. The small Lexington-based biotech, Alzheon, reported promising data at the same conference in France from an early-stage trial of its pill to inhibit the formation of amyloid clumps in the brain.

As quoted from bizjournals.com.  Read the full article here
2016-12-06T09:34:42+00:00March 20th, 2015|Tags: |